Niva Bupa shares list at 6% premium over IPO price
“Investors who participated in the IPO can consider holding their shares, but should closely monitor the company's performance,” says Shivani Nyati of Swastika Investmart.
“Investors who participated in the IPO can consider holding their shares, but should closely monitor the company's performance,” says Shivani Nyati of Swastika Investmart.
The grey market premium (GMP) of the health insurance company has fallen to zero from ₹3 after the IPO received tepid response from investors.
Niva Bupa Health Insurance had filed its DRHP with the SEBI on June 29 this year, while Paras Healthcare submitted IPO papers on July 31.
Fresh shares worth ₹800 crore will be issued by the company as part of the initial offering.